Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

MiniMed Group (MMED) 10K Form and Latest SEC Filings 2026

MiniMed Group logo
$11.51 +0.62 (+5.68%)
As of 02:04 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Latest MiniMed Group SEC Filings & Recent Activity

MiniMed Group (NASDAQ:MMED) has submitted 37+ documents to the U.S. Securities and Exchange Commission (SEC) since 2025. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. The most recent filing was a Form 8-K submitted on May 18, 2026.

Form 4
MiniMed Group, Inc. Reports Ownership Change on Mar. 27, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
MiniMed Group Files Current Report on May. 18, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
MiniMed Group Files Quarterly Report on Apr. 17, 2026

The 10-Q contains MiniMed Group's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

MiniMed Group SEC Filing History

Browse MiniMed Group's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/18/2026 4:09 PM
MiniMed Group (2062583) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2026 7:11 PM
Medtronic plc (1613103) Filed by
MiniMed Group (2062583) Subject
Form SCHEDULE 13G
04/27/2026 7:00 AM
MiniMed Group (2062583) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2026 3:29 PM
MiniMed Group (2062583) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/27/2026 3:31 PM
Dallara Que (1756652) Reporting
MiniMed Group (2062583) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2026 7:00 AM
MiniMed Group (2062583) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2026 6:26 PM
MiniMed Group (2062583) Issuer
Wills Courtney Nelson (2110477) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2026 6:26 PM
Chandrasena Gillian (2111466) Reporting
MiniMed Group (2062583) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2026 6:27 PM
Gyurci John (1850688) Reporting
MiniMed Group (2062583) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2026 6:25 PM
Dianaty Ali (2111492) Reporting
MiniMed Group (2062583) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2026 6:23 PM
Dallara Que (1756652) Reporting
MiniMed Group (2062583) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2026 6:24 PM
MiniMed Group (2062583) Issuer
Spooner Chad (2111465) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2026 3:12 PM
MiniMed Group (2062583) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2026 5:14 PM
Dallara Que (1756652) Reporting
MiniMed Group (2062583) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/06/2026 5:14 PM
MiniMed Group (2062583) Issuer
Spooner Chad (2111465) Reporting
Form 3
Initial statement of beneficial ownership of securities  
03/06/2026 5:14 PM
Dianaty Ali (2111492) Reporting
MiniMed Group (2062583) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/06/2026 5:14 PM
MiniMed Group (2062583) Issuer
Wills Courtney Nelson (2110477) Reporting
Form 3
Initial statement of beneficial ownership of securities  
03/06/2026 5:14 PM
Chandrasena Gillian (2111466) Reporting
MiniMed Group (2062583) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/06/2026 5:14 PM
Gyurci John (1850688) Reporting
MiniMed Group (2062583) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/06/2026 5:14 PM
Lofton Kevin E (1468818) Reporting
MiniMed Group (2062583) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/06/2026 5:14 PM
EISENBERG GLENN A (1222831) Reporting
MiniMed Group (2062583) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/06/2026 5:14 PM
GROSSMAN D KEITH (1218702) Reporting
MiniMed Group (2062583) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/06/2026 5:15 PM
Hopkins Robert (0) Bob
MiniMed Group (2062583) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/06/2026 5:15 PM
MiniMed Group (2062583) Issuer
Wicks Timothy A (1339919) Reporting
Form 3
Initial statement of beneficial ownership of securities  
03/06/2026 5:15 PM
Mauri Laura (2111909) Reporting
MiniMed Group (2062583) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/06/2026 5:15 PM
MiniMed Group (2062583) Issuer
Walter Matthew R. (2028475) Reporting
Form 3
Initial statement of beneficial ownership of securities  
03/06/2026 5:15 PM
MiniMed Group (2062583) Issuer
Wall Brett A. (1473812) Reporting
Form 3
Initial statement of beneficial ownership of securities  
03/06/2026 3:37 PM
MiniMed Group (2062583) Filer
Form 424B4
03/05/2026 11:15 PM
MiniMed Group (2062583) Filer
Form EFFECT
03/05/2026 7:39 PM
Medtronic plc (1613103) Reporting
MiniMed Group (2062583) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/05/2026 7:40 PM
MiniMed Group (2062583) Issuer
Sandstrom Brian (2114422) Reporting
Form 3
Initial statement of beneficial ownership of securities  
03/05/2026 7:40 PM
Eso Christopher (2114423) Reporting
MiniMed Group (2062583) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/05/2026 1:21 PM
MiniMed Group (2062583) Filer
Form CERT
03/05/2026 8:59 AM
MiniMed Group (2062583) Filer
Form 8-A12B
02/24/2026 5:34 AM
MiniMed Group (2062583) Filer
Form S-1/A
01/23/2026 3:09 PM
MiniMed Group (2062583) Filer
Form S-1/A
12/19/2025 3:03 PM
MiniMed Group (2062583) Filer
Form S-1
Registration statement under Securities Act of 1933  
(Data available from 1/1/2016 forward)

MiniMed Group SEC Filings - Frequently Asked Questions

MiniMed Group (MMED) has submitted 37+ filings to the SEC since 2025. You can browse the complete history or filter by form type using the tools above.

The most recent filing was a Form 8-K submitted on May 18, 2026. This was a current report on a material business event.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:MMED) was last updated on 5/20/2026 by MarketBeat.com Staff.
From Our Partners